Modulation of structured polypeptide specificity
US10870679B2 · kind B2 · utility
7Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2018 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Jun 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/6445
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes peptide ligands specific for human plasma Kallikrein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.